SCHEMBL29960359

SCHEMBL29960359

CCOC(=O)/C=C/c1c(O)cccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
CA12 O43570 2/20 0.51
CA1 P00915 2/20 0.51
CA2 P00918 2/20 0.51
CA7 P43166 2/20 0.51
CA9 Q16790 2/20 0.51
CA14 Q9ULX7 2/20 0.51
TTR P02766 1/20 0.51
DPP4 P27487 1/20 0.51
CYP3A4 P08684 1/20 0.49
LMNA P02545 2/20 0.47
MAOB P27338 1/20 0.47
CNKSR1 Q969H4 1/20 0.46
TDP1 Q9NUW8 2/20 0.44
HPGD P15428 2/20 0.44
GLA P06280 1/20 0.44
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1925467 0.91 L3MBTL1 (0.57) MAPTL3MBTL1CA12CA1CA2
SCHEMBL1925465 0.91 L3MBTL1 (0.57) MAPTL3MBTL1CA12CA1CA2
SCHEMBL15826997 0.84 KMT2A (0.55) MAPTL3MBTL1CA12CA1CA2
SCHEMBL2200892 0.84 KMT2A (0.55) MAPTL3MBTL1CA12CA1CA2
SCHEMBL18069260 0.84 L3MBTL1 (0.51) MAPTL3MBTL1CA12CA1CA2
SCHEMBL2200893 0.84 KMT2A (0.55) MAPTL3MBTL1CA12CA1CA2
SCHEMBL29421511 0.82 CA12 (0.51) MAPTCA12CA1CA2CA7
SCHEMBL11352868 0.81 L3MBTL1 (0.48) MAPTL3MBTL1CA12CA1CA2
SCHEMBL11261412 0.78 IAPP (0.54) MAPTLMNATDP1HPGDGLA
SCHEMBL11261408 0.78 IAPP (0.54) MAPTLMNATDP1HPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed